AI improves image quality, but there are important limitations of postprocessing algorithms https://doi.org/10.1148/ryai.260100 #ASER2026 #EMRad #radiology

Understanding the 2024 CLAIM update with examples and clarifications https://doi.org/10.1148/ryai.260835 #ASER2026 #EMRad #radiology

Deep Learning Analysis of Dual-Modality US Videos for the Characterization of Superficial Lymphadenopathy https://doi.org/10.1148/ryai.260131 #ASER2026 #EMRad #radiology

After the 2024 FDA guidance, adoption of Predetermined Change Control Plans (PCCPs) increased among radiology AI devices, but better reporting transparency is needed. https://doi.org/10.1148/ryai.260385 #ASER2026 #EMRad #radiology

Human-AI Collaboration in Radiology: The Blind Spots https://pubs.rsna.org/doi/10.1148/ryai.260325 shk03.bsky.social #ASER2026 #EMRad #radiology

AI improves image quality, but there are important limitations of postprocessing algorithms https://doi.org/10.1148/ryai.260100 #ASER2026 #EMRad #radiology

Checklist for Artificial Intelligence in Medical Imaging (CLAIM): Explanation, Elaboration, and Examples https://doi.org/10.1148/ryai.260835 #ASER2026 #EMRad #radiology

DMUVL-DiagNet: a new model for accurate characterization of superficial LA using dual-modality US videos https://doi.org/10.1148/ryai.260131 #ASER2026 #EMRad #radiology

Predetermined Change Control Plan Adoption and Documentation Transparency in U.S. Food and Drug Administration–cleared Radiology Artificial Intelligence/Machine Learning Devices https://doi.org/10.1148/ryai.260385 #ASER2026 #EMRad #radiology

Human-AI Collaboration in Radiology: The Blind Spots https://pubs.rsna.org/doi/10.1148/ryai.260325 shk03.bsky.social #ASER2026 #EMRad #radiology

Image Quality in the Era of Artificial Intelligence: Understanding the Limitations of AI-based Image Reconstruction and Postprocessing https://doi.org/10.1148/ryai.260100 #ASER2026 #EMRad #radiology

Checklist for Artificial Intelligence in Medical Imaging (CLAIM): Explanation, Elaboration, and Examples https://doi.org/10.1148/ryai.260835 #ASER2026 #EMRad #radiology

Deep Learning Analysis of Dual-Modality US Videos for the Characterization of Superficial Lymphadenopathy https://doi.org/10.1148/ryai.260131 #ASER2026 #EMRad #radiology

Predetermined Change Control Plan Adoption and Documentation Transparency in U.S. Food and Drug Administration–cleared Radiology Artificial Intelligence/Machine Learning Devices https://doi.org/10.1148/ryai.260385 #ASER2026 #EMRad #radiology

New Special Report! Three underexplored domains drive the success of human-AI collaboration in radiology https://pubs.rsna.org/doi/10.1148/ryai.260325 shk03.bsky.social #ASER2026 #EMRad #radiology

Image Quality in the Era of Artificial Intelligence: Understanding the Limitations of AI-based Image Reconstruction and Postprocessing https://doi.org/10.1148/ryai.260100 #ASER2026 #EMRad #radiology

Understanding the 2024 CLAIM update with examples and clarifications https://doi.org/10.1148/ryai.260835 #ASER2026 #EMRad #radiology

Deep Learning Analysis of Dual-Modality US Videos for the Characterization of Superficial Lymphadenopathy https://doi.org/10.1148/ryai.260131 #ASER2026 #EMRad #radiology

After the 2024 FDA guidance, adoption of Predetermined Change Control Plans (PCCPs) increased among radiology AI devices, but better reporting transparency is needed. https://doi.org/10.1148/ryai.260385 #ASER2026 #EMRad #radiology

Human-AI Collaboration in Radiology: The Blind Spots https://pubs.rsna.org/doi/10.1148/ryai.260325 shk03.bsky.social #ASER2026 #EMRad #radiology